Author:
Zhang Hailong,Matsuda Hisashi,Kumahara Akira,Ito Yuki,Nakamura Seikou,Yoshikawa Masayuki
Subject
Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry
Reference26 articles.
1. Davis, S. N.; Granner, D. K. In Insulin, Oral Hypoglycemic Agents, and the Pharmacology of the Endocrine Pancreas; Hardman, J. G., Limbird, L. E., Gilman, A. G., Eds.; Goodman & Gilman’s The Pharmacological Basis of Therapeutics; McGraw-Hill: New York, 2001; pp 1679–1714.
2. Troglitazone: the discovery and development of a novel therapy for the treatment of Type 2 diabetes mellitus
3. Nuclear Receptors as Targets for Drug Development: Molecular Mechanisms for Regulation of Obesity and Insulin Resistance by Peroxisome Proliferator-Activated Receptor γ, CREB-Binding Protein, and Adiponectin
4. Adiponectin and Adiponectin Receptors
5. Ginsenoside 20(S)-Protopanaxatriol (PPT) Activates Peroxisome Proliferator-Activated Receptor γ (PPARγ) in 3T3-L1 Adipocytes
Cited by
114 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献